We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$700M
AUM Growth
+$3.92M
Cap. Flow
+$12.1M
Cap. Flow %
1.73%
Top 10 Hldgs %
36.05%
Holding
81
New
2
Increased
31
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$24.2M
2
PFE icon
Pfizer
PFE
+$16.3M
3
ICL icon
ICL Group
ICL
+$8.29M
4
JCI icon
Johnson Controls International
JCI
+$6.36M
5
FCX icon
Freeport-McMoran
FCX
+$6.23M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$8.25M
2
R icon
Ryder
R
+$7.84M
3
DD
Du Pont De Nemours E I
DD
+$7.79M
4
BG icon
Bunge Global
BG
+$6.98M
5
TDC icon
Teradata
TDC
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 25.81%
2 Financials 15.56%
3 Technology 12.94%
4 Consumer Staples 10.96%
5 Materials 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEM
26
DELISTED
Select Medical
SEM
$12.1M 1.73%
1,561,419
-289,908
-16% -$2.11M
RGA icon
27
Reinsurance Group of America
RGA
$15.7B
$12M 1.71%
136,596
-4,433
-3% -$370K
ANF icon
28
Abercrombie & Fitch
ANF
$4.41B
$11.5M 1.64%
400,013
+113,117
+39% +$3.47M
COP icon
29
ConocoPhillips
COP
$141B
$9.29M 1.33%
134,514
+18,320
+16% +$1.28M
MRK icon
30
Merck
MRK
$323B
$9.15M 1.31%
168,845
+356
+0.2% +$19.8K
KN icon
31
Knowles
KN
$3.2B
$8.91M 1.27%
378,478
+128,606
+51% +$2.66M
NSC icon
32
Norfolk Southern
NSC
$77.1B
$8.12M 1.16%
74,075
-41,800
-36% -$4.58M
CAH icon
33
Cardinal Health
CAH
$53.7B
$8.1M 1.16%
100,272
+10
+0% +$790
CSX icon
34
CSX Corp
CSX
$96B
$8.05M 1.15%
666,354
-165,111
-20% -$1.93M
TPR icon
35
Tapestry
TPR
$29.8B
$8M 1.14%
212,995
-56,676
-21% -$2M
HWC icon
36
Hancock Whitney
HWC
$6.07B
$7.92M 1.13%
258,063
+10
+0% +$325
DBD
37
DELISTED
Diebold Nixdorf Incorporated
DBD
$7.8M 1.11%
225,134
-124,806
-36% -$4.4M
KT icon
38
KT
KT
$8.92B
$7.59M 1.08%
537,379
+181,034
+51% +$2.7M
DOX icon
39
Amdocs
DOX
$5.64B
$6.66M 0.95%
142,669
-40,430
-22% -$1.89M
PTR
40
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$5.86M 0.84%
52,765
+10,539
+25% +$1.22M
TAP icon
41
Molson Coors Class B
TAP
$7.71B
$5.35M 0.76%
71,751
-25,650
-26% -$1.9M
ORCL icon
42
Oracle
ORCL
$345B
$5.32M 0.76%
118,215
+14,990
+15% +$610K
SNY icon
43
Sanofi
SNY
$105B
$5.18M 0.74%
113,547
+7,294
+7% +$354K
DVN icon
44
Devon Energy
DVN
$49.8B
$5.15M 0.74%
84,152
+11,810
+16% +$716K
F icon
45
Ford
F
$58.5B
$4.97M 0.71%
320,569
+1,060
+0.3% +$15.6K
CCU icon
46
Compañía de Cervecerías Unidas
CCU
$2.2B
$4.77M 0.68%
256,989
+116,442
+83% +$2.37M
JBL icon
47
Jabil
JBL
$32.6B
$4.41M 0.63%
202,038
-245,508
-55% -$4.99M
FNB icon
48
FNB Corp
FNB
$6.71B
$4.35M 0.62%
326,662
+660
+0.2% +$8.3K
MTB icon
49
M&T Bank
MTB
$36B
$4.21M 0.6%
33,524
+100
+0.3% +$12.3K
RDS.A
50
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4.11M 0.59%
61,351
+4,870
+9% +$337K

Similar funds

Foyston, Gordon, & Payne's Q4 2014 Portfolio in Review

As of Q4 2014, Foyston, Gordon, & Payne held 81 positions worth $700M, up 0.56% from $696M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Foyston, Gordon, & Payne's Q4 2014 filing shows 2 new, 31 increased, 29 reduced and 5 closed positions. Its largest new stake was Verizon: 494,691 shares worth $23.1M. The largest sale was Baker Hughes, an estimated $8.25M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

  • Foyston, Gordon, & Payne's largest Q4 2014 buy was Verizon: 494,691 shares worth $23.1M.
  • Foyston, Gordon, & Payne added most to ICL Group in Q4 2014, an estimated $8.29M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2014 reduction was Baker Hughes, cutting an estimated $8.25M.
  • Foyston, Gordon, & Payne fully exited Ryder in Q4 2014, selling an estimated $7.84M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 36% of its $700M portfolio in Q4 2014.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 5 in Q4 2014.
  • Foyston, Gordon, & Payne's portfolio value rose 0.56% quarter-over-quarter to $700M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2014, filed 13 Feb 2015.